Editorial: incorporating liver stiffness to risk scores for HCC in patients with chronic hepatitis B treated with oral antivirals: ready to use or not?

LINKED CONTENT This article is linked to Chon et al paper. To view this article, visit https://doi.org/10.1111/apt.16267

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2021-03, Vol.53 (6), p.753-754
Hauptverfasser:	Yang, Hwai‐I, Hsu, Yao‐Chun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Antiviral Agents - therapeutic use Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - epidemiology Hepatitis B Hepatitis B, Chronic - complications Hepatitis B, Chronic - drug therapy Humans Interferon Liver Cirrhosis - drug therapy Liver Neoplasms - drug therapy Liver Neoplasms - epidemiology Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	LINKED CONTENT This article is linked to Chon et al paper. To view this article, visit https://doi.org/10.1111/apt.16267
ISSN:	0269-2813 1365-2036
DOI:	10.1111/apt.16279